Tuberous Sclerosis (TS) Alliance: Research Grants Program 2018

The TS Alliance endeavors to stimulate, support and coordinate research that will lead to a cure for tuberous sclerosis complex (TSC) while improving the lives of those affected.

Research plans should address one of the following four high-priority areas:

  • understanding phenotypic heterogeneity in TSC, i.e., research on genetic, biologic, or environmental factors that might explain why TSC is so different from person to person;
  • gaining a deeper knowledge of TSC signaling pathways and the cellular consequences of TSC deficiency;
  • improving TSC disease models, whether cell-based, tissue-based, or animal models;
  • developing clinical biomarkers or patient-reported outcome measures for TSC, particularly those that assess disease burden or stratify an individual’s risk of progression or developing specific manifestations of TSC.

Funding & Duration

Up to US $75,000 (approx. AUD $96,000) per year for two years.


This opportunity is open to all investigators at established academic or research institutions or at pharmaceutical or biotech companies worldwide.

Submission Requirements & Due Dates

Further Information

Need Help?

This entry was posted in Funding by Award Type, Funding by Faculty, Grants (Project Funds), Health & Medical Sciences, International Funding. Bookmark the permalink.

Comments are closed.